The only current adjuvant systemic treatment option in TNBC is chemotherapy. There is no defined standard chemotherapy, and chemotherapy use should not be different for TNBC and non-TNBC

Patients with triple negative breast cancer / Di Leo A; Oakman C; Moretti E; Galardi F; Biagioni C; Santarpia. - In: THE BREAST. - ISSN 0960-9776. - ELETTRONICO. - (2011), pp. S13-S14.

Patients with triple negative breast cancer.

MORETTI, ERICA;
2011

Abstract

The only current adjuvant systemic treatment option in TNBC is chemotherapy. There is no defined standard chemotherapy, and chemotherapy use should not be different for TNBC and non-TNBC
2011
Di Leo A; Oakman C; Moretti E; Galardi F; Biagioni C; Santarpia
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/958145
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact